Preparation method of paclitaxel injection resistant to terminal sterilization
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SICHUAN HUIYU PHARMA
- Publication Date
- 2019-08-16
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to a method for preparing paclitaxel injection, in particular to a method for preparing paclitaxel injection resistant to terminal sterilization, and belongs to the technical field of pharmaceutical preparations. Background technique
[0002] Paclitaxel is an antineoplastic drug extracted from Taxus chinensis. It has a unique mechanism of action, by inducing and promoting tubulin polymerization, assembly and stabilizing microtubules, preventing the growth of tumor cells, and has curative effects on ovarian cancer, breast cancer, head and neck cancer, non-small cell lung cancer and prostate cancer Significantly, it is a broad-spectrum anticancer drug. Paclitaxel and its injection were first developed by Bristol-Myers Squibb Company. In 1992, it was approved by FDA to enter the US market for the first time, and it has been widely used in the world.
[0003] Due to the complex structure of paclitaxel, it is unstable to heat, alkali...